A review of perioperative corticosteroid use in dentoalveolar surgery.
Identifieur interne : 000534 ( Main/Exploration ); précédent : 000533; suivant : 000535A review of perioperative corticosteroid use in dentoalveolar surgery.
Auteurs : R E Alexander [États-Unis] ; R R ThrondsonSource :
- Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics [ 1079-2104 ] ; 2000.
Descripteurs français
- KwdFr :
- Administration par voie orale (MeSH), Anti-inflammatoires non stéroïdiens (administration et posologie), Contre-indications (MeSH), Hormones corticosurrénaliennes (administration et posologie), Hormones corticosurrénaliennes (effets indésirables), Hormones corticosurrénaliennes (pharmacocinétique), Humains (MeSH), Injections musculaires (MeSH), Injections veineuses (MeSH), Modèles de pratique odontologique (MeSH), Oedème (prévention et contrôle), Oedème (étiologie), Procédures de chirurgie maxillofaciale et buccodentaire (effets indésirables), Utilisation médicament (MeSH), Équivalence thérapeutique (MeSH).
- MESH :
- administration et posologie : Anti-inflammatoires non stéroïdiens, Hormones corticosurrénaliennes.
- effets indésirables : Hormones corticosurrénaliennes, Procédures de chirurgie maxillofaciale et buccodentaire.
- pharmacocinétique : Hormones corticosurrénaliennes.
- prévention et contrôle : Oedème.
- étiologie : Oedème.
- Administration par voie orale, Contre-indications, Humains, Injections musculaires, Injections veineuses, Modèles de pratique odontologique, Utilisation médicament, Équivalence thérapeutique.
English descriptors
- KwdEn :
- Administration, Oral (MeSH), Adrenal Cortex Hormones (administration & dosage), Adrenal Cortex Hormones (adverse effects), Adrenal Cortex Hormones (pharmacokinetics), Anti-Inflammatory Agents, Non-Steroidal (administration & dosage), Contraindications (MeSH), Drug Utilization (MeSH), Edema (etiology), Edema (prevention & control), Humans (MeSH), Injections, Intramuscular (MeSH), Injections, Intravenous (MeSH), Oral Surgical Procedures (adverse effects), Practice Patterns, Dentists' (MeSH), Therapeutic Equivalency (MeSH).
- MESH :
- chemical , administration & dosage : Adrenal Cortex Hormones, Anti-Inflammatory Agents, Non-Steroidal.
- chemical , adverse effects : Adrenal Cortex Hormones.
- chemical , pharmacokinetics : Adrenal Cortex Hormones.
- adverse effects : Oral Surgical Procedures.
- etiology : Edema.
- prevention & control : Edema.
- Administration, Oral, Contraindications, Drug Utilization, Humans, Injections, Intramuscular, Injections, Intravenous, Practice Patterns, Dentists', Therapeutic Equivalency.
Abstract
OBJECTIVES
Dental surgeons are often advised to use corticosteroids during and after third molar removal and other dentoalveolar surgery to reduce postsurgical edema, but recommendations for use are rarely accompanied by definitive guidance regarding the type of steroid, dosage, or duration of administration. Many regimens in use appear to be based on anecdotal information from articles in the 1960s and 1970s and might be subtherapeutic. Few regimens have been updated with data from more recent studies, and well-designed comparison studies are lacking.
STUDY DESIGN
In this article, the literature from the past 30 years is reviewed, meaningful findings are highlighted, and available data are used as a basis for formulating interim clinical recommendations for corticosteroid use pending the emergence of more evidence-based data. A meta-analysis of data was not performed.
RESULTS
Recent data suggest that perioperative corticosteroid regimens should be administered in higher doses and for longer durations than recommended in the past and should be started before surgery for optimum benefit.
CONCLUSIONS
Based on the literature review, interim recommendations for the use of corticosteroids are proposed, including dosages and regimens that appear rational for oral, intramuscular, or intravenous corticosteroid administration before and after extractions and other dentoalveolar surgery. These largely empiric recommendations might require adjustment when evidence-based data become available in future studies. There is a great need for well-designed clinical research to further evaluate protocols for corticosteroid use.
DOI: 10.1067/moe.2000.109778
PubMed: 11027375
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A review of perioperative corticosteroid use in dentoalveolar surgery.</title><author><name sortKey="Alexander, R E" sort="Alexander, R E" uniqKey="Alexander R" first="R E" last="Alexander">R E Alexander</name><affiliation wicri:level="1"><nlm:affiliation>Baylor College of Dentistry, Texas A&M University System Health Science Center, Dallas 75266-0677, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Baylor College of Dentistry, Texas A&M University System Health Science Center, Dallas 75266-0677</wicri:regionArea><placeName><settlement type="city">Dallas</settlement><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Throndson, R R" sort="Throndson, R R" uniqKey="Throndson R" first="R R" last="Throndson">R R Throndson</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2000">2000</date><idno type="RBID">pubmed:11027375</idno><idno type="pmid">11027375</idno><idno type="doi">10.1067/moe.2000.109778</idno><idno type="wicri:Area/Main/Corpus">000529</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000529</idno><idno type="wicri:Area/Main/Curation">000529</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000529</idno><idno type="wicri:Area/Main/Exploration">000529</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A review of perioperative corticosteroid use in dentoalveolar surgery.</title><author><name sortKey="Alexander, R E" sort="Alexander, R E" uniqKey="Alexander R" first="R E" last="Alexander">R E Alexander</name><affiliation wicri:level="1"><nlm:affiliation>Baylor College of Dentistry, Texas A&M University System Health Science Center, Dallas 75266-0677, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Baylor College of Dentistry, Texas A&M University System Health Science Center, Dallas 75266-0677</wicri:regionArea><placeName><settlement type="city">Dallas</settlement><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Throndson, R R" sort="Throndson, R R" uniqKey="Throndson R" first="R R" last="Throndson">R R Throndson</name></author></analytic><series><title level="j">Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics</title><idno type="ISSN">1079-2104</idno><imprint><date when="2000" type="published">2000</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Oral (MeSH)</term><term>Adrenal Cortex Hormones (administration & dosage)</term><term>Adrenal Cortex Hormones (adverse effects)</term><term>Adrenal Cortex Hormones (pharmacokinetics)</term><term>Anti-Inflammatory Agents, Non-Steroidal (administration & dosage)</term><term>Contraindications (MeSH)</term><term>Drug Utilization (MeSH)</term><term>Edema (etiology)</term><term>Edema (prevention & control)</term><term>Humans (MeSH)</term><term>Injections, Intramuscular (MeSH)</term><term>Injections, Intravenous (MeSH)</term><term>Oral Surgical Procedures (adverse effects)</term><term>Practice Patterns, Dentists' (MeSH)</term><term>Therapeutic Equivalency (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Administration par voie orale (MeSH)</term><term>Anti-inflammatoires non stéroïdiens (administration et posologie)</term><term>Contre-indications (MeSH)</term><term>Hormones corticosurrénaliennes (administration et posologie)</term><term>Hormones corticosurrénaliennes (effets indésirables)</term><term>Hormones corticosurrénaliennes (pharmacocinétique)</term><term>Humains (MeSH)</term><term>Injections musculaires (MeSH)</term><term>Injections veineuses (MeSH)</term><term>Modèles de pratique odontologique (MeSH)</term><term>Oedème (prévention et contrôle)</term><term>Oedème (étiologie)</term><term>Procédures de chirurgie maxillofaciale et buccodentaire (effets indésirables)</term><term>Utilisation médicament (MeSH)</term><term>Équivalence thérapeutique (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Adrenal Cortex Hormones</term><term>Anti-Inflammatory Agents, Non-Steroidal</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Adrenal Cortex Hormones</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Adrenal Cortex Hormones</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Anti-inflammatoires non stéroïdiens</term><term>Hormones corticosurrénaliennes</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Oral Surgical Procedures</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Hormones corticosurrénaliennes</term><term>Procédures de chirurgie maxillofaciale et buccodentaire</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Edema</term></keywords><keywords scheme="MESH" qualifier="pharmacocinétique" xml:lang="fr"><term>Hormones corticosurrénaliennes</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Edema</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Oedème</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Oedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Administration, Oral</term><term>Contraindications</term><term>Drug Utilization</term><term>Humans</term><term>Injections, Intramuscular</term><term>Injections, Intravenous</term><term>Practice Patterns, Dentists'</term><term>Therapeutic Equivalency</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Administration par voie orale</term><term>Contre-indications</term><term>Humains</term><term>Injections musculaires</term><term>Injections veineuses</term><term>Modèles de pratique odontologique</term><term>Utilisation médicament</term><term>Équivalence thérapeutique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>OBJECTIVES</b></p><p>Dental surgeons are often advised to use corticosteroids during and after third molar removal and other dentoalveolar surgery to reduce postsurgical edema, but recommendations for use are rarely accompanied by definitive guidance regarding the type of steroid, dosage, or duration of administration. Many regimens in use appear to be based on anecdotal information from articles in the 1960s and 1970s and might be subtherapeutic. Few regimens have been updated with data from more recent studies, and well-designed comparison studies are lacking.</p></div><div type="abstract" xml:lang="en"><p><b>STUDY DESIGN</b></p><p>In this article, the literature from the past 30 years is reviewed, meaningful findings are highlighted, and available data are used as a basis for formulating interim clinical recommendations for corticosteroid use pending the emergence of more evidence-based data. A meta-analysis of data was not performed.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Recent data suggest that perioperative corticosteroid regimens should be administered in higher doses and for longer durations than recommended in the past and should be started before surgery for optimum benefit.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>Based on the literature review, interim recommendations for the use of corticosteroids are proposed, including dosages and regimens that appear rational for oral, intramuscular, or intravenous corticosteroid administration before and after extractions and other dentoalveolar surgery. These largely empiric recommendations might require adjustment when evidence-based data become available in future studies. There is a great need for well-designed clinical research to further evaluate protocols for corticosteroid use.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">11027375</PMID><DateCompleted><Year>2000</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1079-2104</ISSN><JournalIssue CitedMedium="Print"><Volume>90</Volume><Issue>4</Issue><PubDate><Year>2000</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics</Title><ISOAbbreviation>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</ISOAbbreviation></Journal><ArticleTitle>A review of perioperative corticosteroid use in dentoalveolar surgery.</ArticleTitle><Pagination><MedlinePgn>406-15</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Dental surgeons are often advised to use corticosteroids during and after third molar removal and other dentoalveolar surgery to reduce postsurgical edema, but recommendations for use are rarely accompanied by definitive guidance regarding the type of steroid, dosage, or duration of administration. Many regimens in use appear to be based on anecdotal information from articles in the 1960s and 1970s and might be subtherapeutic. Few regimens have been updated with data from more recent studies, and well-designed comparison studies are lacking.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">In this article, the literature from the past 30 years is reviewed, meaningful findings are highlighted, and available data are used as a basis for formulating interim clinical recommendations for corticosteroid use pending the emergence of more evidence-based data. A meta-analysis of data was not performed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Recent data suggest that perioperative corticosteroid regimens should be administered in higher doses and for longer durations than recommended in the past and should be started before surgery for optimum benefit.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Based on the literature review, interim recommendations for the use of corticosteroids are proposed, including dosages and regimens that appear rational for oral, intramuscular, or intravenous corticosteroid administration before and after extractions and other dentoalveolar surgery. These largely empiric recommendations might require adjustment when evidence-based data become available in future studies. There is a great need for well-designed clinical research to further evaluate protocols for corticosteroid use.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alexander</LastName><ForeName>R E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Baylor College of Dentistry, Texas A&M University System Health Science Center, Dallas 75266-0677, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Throndson</LastName><ForeName>R R</ForeName><Initials>RR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</MedlineTA><NlmUniqueID>9508562</NlmUniqueID><ISSNLinking>1079-2104</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical></ChemicalList><CitationSubset>D</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000075202" MajorTopicYN="N">Contraindications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004363" MajorTopicYN="N">Drug Utilization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004487" MajorTopicYN="N">Edema</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007273" MajorTopicYN="N">Injections, Intramuscular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007275" MajorTopicYN="N">Injections, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019647" MajorTopicYN="Y">Oral Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019239" MajorTopicYN="N">Practice Patterns, Dentists'</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013810" MajorTopicYN="N">Therapeutic Equivalency</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>38</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2000</Year><Month>10</Month><Day>12</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>2</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2000</Year><Month>10</Month><Day>12</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11027375</ArticleId><ArticleId IdType="pii">S1079-2104(00)32699-3</ArticleId><ArticleId IdType="doi">10.1067/moe.2000.109778</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Texas</li></region><settlement><li>Dallas</li></settlement></list><tree><noCountry><name sortKey="Throndson, R R" sort="Throndson, R R" uniqKey="Throndson R" first="R R" last="Throndson">R R Throndson</name></noCountry><country name="États-Unis"><region name="Texas"><name sortKey="Alexander, R E" sort="Alexander, R E" uniqKey="Alexander R" first="R E" last="Alexander">R E Alexander</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SuicidDentistV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000534 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000534 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SuicidDentistV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:11027375
|texte= A review of perioperative corticosteroid use in dentoalveolar surgery.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:11027375" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SuicidDentistV1
| This area was generated with Dilib version V0.6.39. |  |